FDA NDC Directory · JSON-LD · Markdown

Enoxaparin Sodium

NDC 68001-641 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerBluePoint Laboratories
Marketing categoryAbbreviated NDA (generic) · App ANDA214856
Dosage form / routeINJECTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsENOXAPARIN SODIUM (300 mg/3mL)
Marketing started20250501
Package count1

External sources

Source: openFDA. Public-domain (CC0).